Bonesupport: Stronger commercial platform to make strategic inroads
The investment in the US and European commercial platforms should begin to bear fruit in the coming quarters, helping to achieve the targeted >40% sales CAGR post-2019. Q318 had been well flagged as the nadir for US sales following the termination of the Zimmer Biomet exclusive US distribution agreement. With the new 25-strong US distributor network selling CERAMENT BVF direct from October 22, and European sales expansion on track, market penetration should accelerate. Increasing sales activity, imminent top-line data from the CERTiFy study (CERAMENT BVF in trauma), and new H119 product launches should boost future sales. Our valuation is SEK2,042m or SEK37/share.Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
We are experienced healthcare and life sciences analysts providing the highest quality service to companies in these sectors and to investors. We have expertise in the fields of the biotech, medtech , specialty pharma and consumer health sectors.
The old-fashioned values of the City enabled London to become a global financial centre, and we pride ourselves for our integrity and professionalism, where our word is our bond. This applies to our research, and all interactions with companies, the buyside and other partners.
We also firmly believe that by putting our clients first, we create long term value for all stakeholders.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.